SiNtx Technologies Inc (SINT)

[boston745]

Meanwhile on the Personnel side of things, Centerpulse & then Zimmer has been involved. This does not represent an exhaustive list of personnel connected between the two companies, only to highlight that someone connected to Zimmer (before it Centerpulse) has been at the helm of Sintx since its founding.

That makes Personnel connected to Zimmer
Product R&D connected to Biomet
Chief external scientific researcher connected to Biomet.
Zimmer + Biomet = Zimmer Biomet June 2015


Founded 1996

Dr. Hofmann, MD

Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996. Dr. Hofmann is a nationally and internationally recognized orthopedic surgeon, known for his accomplishments in developing total hip and knee replacement systems, innovative surgical approaches in hip and knee surgery and basic research on human bone dynamics. Dr. Hofmann holds 14 patents, many of which are directed at inventions involving hip and knee implants. Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc., the largest orthopedics company in the world. Dr. Hofmann, working with a team of orthopedic surgeons, helped design Zimmer’s new gender knee specifically designed for women.

Centerpulse Orthopedics Inc., an Austin-based subsidiary of Switzerland-based Centerpulse AG [NYSE: CEP], on Tuesday unveiled the Natural-Knee Unicompartmental System Instrumentation for partial replacement of the knee joint.
Dr. Aaron Hofmann, an orthopedic surgeon at the University of Utah Medical Center who helped design the Natural-Knee system


Oct 2003

Dr. Max Link, PHD (Chairman 2003-2014)

Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc. Prior to joining Centerpulse, [/color]

The above quote was from Sintx first attempt to IPO in 2007. Now im going to reference another blurb about Dr Link from the 2014 IPO fillings. Notice anything missing?

Max E. Link, Ph.D. has served as the chairman of our board of directors since October 2003. Dr. Link was chairman of the board of directors and Chief Executive Officer of Centerpulse AG, a medical implant company from March 2002 to October 2003. Prior to joining Centerpulse,

Looks like, for some reason, connections between Sintx and Zimmer was purposefully withheld in the 2014 IPO paperwork. Also, in the description of current CEO Dr. Bal, there is no mention of him being a surgeon designer for Zimmer the way this fact was mentioned about Dr. Hofmann on the 2007 IPO paperwork. This despite Dr. Bal's extensive resume showing him as such. Ive included other supportive evidence showing he was a paid consultant for Zimmer. Why do you think this information was withheld at IPO? Certainly if Sintx was a scam, as some like to claim, it would have leaned harder on this information instead of hiding it wouldnt you think?

2012 - Dr Sonny Bal, MD joins Sintx board of directors

B. Sonny Bal, M.D. has served on our board of directors since February 2012. Dr. Bal is Professor & Chief of Adult Reconstruction at the University of Missouri, Columbia, specializing in hip and knee replacement surgery. He also is an Adjunct Professor of Material Sciences at the University of Missouri at Rolla. Dr. Bal is a member of the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons. Dr. Bal received his M.D. degree from Cornell University and an M.B.A. from Northwestern University, and a J.D. from the University of Missouri. Dr. Bal is a licensed attorney and co-founder of the Bal Brenner law firm in North Carolina.

We believe that Dr. Bal’s expertise in orthopedic surgery and his specialty in hip and knee replacement surgery qualifies him to serve on our board of directors.

2014 - Dr Bal becomes Chairman & CEO

Dr. Sonny Bal, MD

Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.

Total Joint Reconstruction Clinical Advisory Panel, Amedica Inc., Salt Lake City, UT, 2005 to present.

Zimmer Holdings, Inc.: “Comparison of tissue-engineered osteochondral grafts fabricated with mesenchymal stem cells and trabecular metal or allograft bone.” $125,406.00. 5/25/2006 to 5/24/2007.
Zimmer Holdings,Inc.: “Design and testing of a canine biological femoral head replacement.” $342,837.00. 7/1/2011 to 6/30/2014.

B. Sonny Bal, MD: 1, 3B – Zimmer; 3C – OMNI, Amedica, Salient, ConforMIS;
4 – Amedica

3a. – Employee
3b. – Paid consultant
3c. – Unpaid consultant

Quote Sources:

1. https://www.sec.gov/Archives/edgar/data/1269026/000119312507120692/ds1.htm pg 74
2. https://web.archive.org/web/20060126100849/https://www.bizjournals.com/austin/stories/2002/12/02/daily15.html
3. https://www.sec.gov/Archives/edgar/data/1269026/000119312507120692/ds1.htm pg 73
4. https://www.sec.gov/Archives/edgar/data/1269026/000119312513435409/d593074ds1.htm pg 89
5. https://www.sec.gov/Archives/edgar/data/1269026/000119312513435409/d593074ds1.htm pg 90
6. https://web.archive.org/web/20240316192627/https://hipandknee.com/wp-content/uploads/2014/04/Dr.-Bal-CV.pdf
7. https://web.archive.org/web/20120602234429/https://www.aaos.org/Education/anmeet/education/Disclosures.pdf

My old link to Dr Bal's 2013 resume experienced a 404 error. Fortunately i found a working link and archived it this time.

========================================

Now ive been purposefully censored on this board being limited to 3 posts a day for months now. So see you tomorrow. Almost like someone does not want the truth out? Too bad for them it just forced me to consolidate information.

You have already reached the 3 post per day limit placed on you for this board.
The limitation is until further notice.

========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779